Unique Ingredient Identifier
Unique Ingredient Identifier (UNII) is a system used to identify substances used in the production of pharmaceutical products. The UNII is a non-proprietary, free, unique, unambiguous, nonsemantic alphanumeric identifier linked to a substance's molecular structure or descriptive information by the United States Food and Drug Administration (FDA) and the United States Pharmacopeia (USP).
Overview[edit | edit source]
The UNII is assigned to substances that are used in the manufacture of pharmaceuticals, including active ingredients, excipients, and other ingredients. The UNII is not a chemical nomenclature, but rather a unique, non-semantic identifier. The UNII is generated based on a substance's molecular structure or descriptive information and is not related to any other identifier or system.
Purpose[edit | edit source]
The purpose of the UNII is to provide a unique identifier for each distinct substance used in the production of pharmaceuticals. This allows for clear communication and data exchange between organizations and systems. The UNII is used in regulatory submissions, labeling, and other applications where a unique identifier is needed.
Assignment[edit | edit source]
The UNII is assigned by the FDA's Substance Registration System (SRS). The SRS is a publicly accessible database that contains information on substances used in the production of pharmaceuticals. The SRS assigns a UNII to each substance in the database based on its molecular structure or descriptive information.
Use[edit | edit source]
The UNII is used in a variety of applications, including regulatory submissions, labeling, and data exchange. The UNII is used to identify substances in the FDA's Structured Product Labeling (SPL) system, which is used to create and manage product labeling. The UNII is also used in the FDA's Adverse Event Reporting System (AERS), which is used to track and analyze adverse events associated with the use of pharmaceutical products.
See also[edit | edit source]
- United States Food and Drug Administration
- United States Pharmacopeia
- Substance Registration System
- Structured Product Labeling
- Adverse Event Reporting System
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
